EP3636778

FRED HUTCHINSON CANCER CENTER
Application Number
EP19190336A
Filing Date
Aug 18, 2011
Status
Revoked
Aug 2, 2024
Grant Date
Jan 12, 2022
External Links
Slate, Register

Biblio Summary

The patent EP3636778B1 was granted on Jan 12, 2022 by Fred Hutchinson Cancer Center The patent is currently Revoked.

The table below shows 2 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

CMS CAMERON MCKENNA NABARRO OLSWANG LLPOct 12, 2022ADMISSIBLE
STRAWMAN LIMITEDOct 11, 2022ADMISSIBLE

The table below shows the patents of Fred Hutchinson Cancer Center that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP3688157High Efficiency Targeted In Situ Genome-Wide ProfilingApr 27, 20221
EP3363901Compositions And Methods For Accurately Identifying MutationsDec 30, 20203
EP2689010Method And Compositions For Cellular ImmunotherapyNov 18, 20201

Dossier Documents of the Patent

The documents dossier of the patent at EPO including all essential records in the patent's lifecycle, from filing to grant to oppositions.